The link between Semaglutide & vision loss (NAION)

How deep is the link between GLP1s and possible vision loss? We examine the

Keeping a keen eye on the negative effects of GLP1 Receptor Agonists is top of mind for us. Knowing the benefits *and* the drawbacks of this incredible class of drugs is important.

Today we take a look at the early July 2024 paper that was first to explore a possible link between Semaglutide and Non-arteritic anterior ischemic optic neuropathy (“NAION”) which stated bluntly is “vision loss from reduced ocular blood flow”.